NFKB1 and lung cancer: Additionally, it was found that the S1 protein of SARS-CoV-2 can activate the NF-κB signalling pathway in lung cancer cells, increase the expression of proinflammatory factors such as TNF-α, and thus induce lung cancer cell death (82).